Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 264,316 | 205,450 | 165,795 | 67,581 | 201,644 |
| Depreciation Amortization | 84,408 | 60,358 | 39,980 | 20,065 | 94,654 |
| Income taxes - deferred | -21,612 | -18,009 | -6,779 | -5,397 | -18,337 |
| Accounts receivable | -28,967 | -21,319 | -18,509 | -28,935 | 47,779 |
| Other Working Capital | -118,711 | -118,300 | -66,033 | -101,888 | -47,084 |
| Other Operating Activity | 147,818 | 102,902 | 75,364 | 56,983 | 88,425 |
| Operating Cash Flow | $327,252 | $211,082 | $189,818 | $8,409 | $367,081 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 73,863 | -2,356 | -2,225 | 6,732 | -117,991 |
| PPE Investments | -30,007 | -22,628 | -15,015 | -6,099 | -30,339 |
| Net Acquisitions | -487,877 | N/A | N/A | N/A | 25,703 |
| Sale Of Investment | 157,729 | N/A | N/A | N/A | 176,833 |
| Investing Cash Flow | $-286,292 | $-24,984 | $-17,240 | $633 | $54,206 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 40,203 | 39,487 | 29,345 | 18,301 | 47,781 |
| Common Stock Repurchased | -160,001 | -139,999 | -104,999 | -80,002 | -149,276 |
| Dividend Paid | -114,579 | -85,971 | -57,268 | -28,552 | -103,407 |
| Other Financing Activity | -53,437 | -41,213 | -36,379 | -34,887 | -31,910 |
| Financing Cash Flow | $-287,814 | $-227,696 | $-169,301 | $-125,140 | $-236,812 |
| Exchange Rate Effect | 6,640 | 2,256 | 3,113 | 6,790 | 5,120 |
| Beginning Cash Position | 817,966 | 817,966 | 817,966 | 817,966 | 628,371 |
| End Cash Position | 577,752 | 778,624 | 824,356 | 708,658 | 817,966 |
| Net Cash Flow | $-240,214 | $-39,342 | $6,390 | $-109,308 | $189,595 |
| Free Cash Flow | |||||
| Operating Cash Flow | 327,252 | 211,082 | 189,818 | 8,409 | 367,081 |
| Capital Expenditure | -30,007 | -22,628 | -15,015 | -6,099 | -30,339 |
| Free Cash Flow | 297,245 | 188,454 | 174,803 | 2,310 | 336,742 |